价格

复方甲苯咪唑

Compound Mebendazole

未知生产厂商

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

适应症

适用于驱蛲虫、蛔虫、钩虫或蛔、钩、鞭虫混合感染。

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

TOPICAL BENZIMIDAZOLE FORMULATIONS AND METHODS FOR USE IN TREATING INFLAMMATORY DERMATOSES
- EP 4543441 A4
  申请人: JJR&D LLC优先权: 2022
  EP
  WO
  2 件公开
- US 20250241898 A1
  申请人: JJR&D LLC优先权: 2024
  US
- WO 2025221973 A1
  申请人: JJR&D LLC优先权: 2025
  WO
Anthelmintic combinations
EP 2468096 A1申请人: INTERVET INT BV优先权: 2010
EP
Compound tablets containing mebendazole and dipterex and used for deworming on pets, and preparation method thereof
CN 104337822 A申请人: QINGDAO KDN BIOTECH CO LTD优先权: 2013
CN
Compound ivermectin injection and preparation method thereof
CN 104306388 A申请人: JIANGXI NEW TOLDHOW PHARMACEUTICAL CO LTD优先权: 2014
CN
Compound anti-parasitic preparation and preparation method thereof
CN 107693532 A申请人: FOSHAN NANHAI EASTERN ALONG PHARMACEUTICAL CO LTD优先权: 2017
CN
Prophylactic or therapeutic agent for pulmonary hypertension comprising mebendazole and/or itraconazole or salt thereof
US 11369601 B2申请人: UNIV TOHOKU优先权: 2017
US
METHOD FOR PREVENTING MUSCLE MELTING OF SALMONIFORMES
CN 112638379 A申请人: NIPPON SUISAN KAISHA LTD优先权: 2018
CN
Mebendazole lipid compound, preparation method and application
CN 113616798 A申请人: UNIV TIANJIN AGRICULTURAL优先权: 2021
CN
一种复方甲苯咪唑透皮溶液剂及其制备方法
CN 114042065 B申请人: 长沙拜特生物科技研究所有限公司优先权: 2021
CN
Mebendazole HP-beta-cyclodextrin inclusion compound and preparation method thereof
CN 120242052 A申请人: WENZHOU KENZEN UNIV WOZEN优先权: 2025
CN

药物

复方甲苯咪唑

适应症

专利

TOPICAL BENZIMIDAZOLE FORMULATIONS AND METHODS FOR USE IN TREATING INFLAMMATORY DERMATOSES